Resubmission of NDA is On Track for First Half of Q2 24
Extended Cash Runway into 2025
https://www.globenewswire.com/news-release/2024/03/06/2841372/0/en/Iterum-Therapeutics-Provides-Business-Update.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.